☆ 4.6 Letter

Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries

BRITISH JOURNAL OF DERMATOLOGY (2013)

Journal

BRITISH JOURNAL OF DERMATOLOGY

Volume 169, Issue 3, Pages 710-714

Publisher

WILEY-BLACKWELL

DOI: 10.1111/bjd.12344

Keywords

*registries; comparative effectiveness; epidemiology; psoriasis; psoriasis; *drug therapy; research

Categories

Dermatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Urology & Nephrology

A European Registry Evaluating Symptomatic Effectiveness of Pharmacologically Treated Patients with Lower Urinary Tract Symptoms due to Benign Prostatic Enlargement: Lessons Learned

Andrea Tubaro, Mark Speakman, Alexandre de la Taille, Louis Martinez-Pineiro, Richard Berges, Anup Patel, Anders Bjartell, Christien Caris, Wim Witjes

Summary: This study evaluated the effectiveness of pharmacological treatment for lower urinary tract symptoms-benign prostatic enlargement in a real-world setting, showing that 70% of previously untreated and 42% of previously treated patients experienced symptom improvement after 24 months. Patients with persistent symptoms (IPSS >= 8) remained in both untreated and treated groups at 59% and 61% respectively, with higher rates of symptom deterioration in the previously treated group compared to the previously untreated group.

JOURNAL OF UROLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

The Danish National Register of assisted reproductive technology: content and research potentials

Line Riis Jolving, Karin Erb, Bente Mertz Norgard, Jens Fedder, Michael Due Larsen

Summary: The Danish National Register of assisted reproductive technology (ART) provides comprehensive information on all ART procedures in Denmark since 2013, making it a valuable tool for monitoring and researching infertility treatment and reproductive topics. Researchers can access aggregated data on ART treatments annually through the Danish Health Data Authority's website and obtain individual pseudonomized data via secure servers for further analysis.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)

Add to Collection

Article Dermatology

Persistence, effectiveness, and real-world outcomes in psoriasis patients treated with secukinumab in Portugal

Pedro Mendes-Bastos, Paulo Morais, Paulo Ferreira, Manuela Loureiro, Joaquina Sanganha, Luis Santiago, Antonio Sousa Basto, Martinha Henrique

Summary: This study characterized adult patients with moderate to severe psoriasis treated with secukinumab, estimated the drug persistence, and assessed the reasons for treatment discontinuation. The study found that longer time since diagnosis, bio-naive or previous use of only one biologic were predictive factors for secukinumab persistence, while the presence of psoriasis on difficult-to-treat locations predicted drug discontinuation.

DERMATOLOGIC THERAPY (2022)

Add to Collection

Article Medicine, General & Internal

Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer

Sreeram Ramagopalan, Alind Gupta, Paul Arora, Kristian Thorlund, Joshua Ray, Vivek Subbiah

Summary: This study compared the effectiveness of atezolizumab, nivolumab, and docetaxel in patients with advanced NSCLC who were resistant to platinum-based chemotherapy. Atezolizumab was found to be superior to docetaxel in prolonging overall survival in this cohort of patients.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Rheumatology

Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study

Denis Mongin, Kim Lauper, Axel Finckh, Thomas Frisell, Delphine Sophie Courvoisier

Summary: This study assessed the performance of statistical methods used to compare drug effectiveness in the presence of attrition. The results showed that only multiple imputation and inverse probability weighting, which considered both confounding and treatment cessation reasons, produced accurate comparative effectiveness estimates.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Article Dermatology

Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO)

Andreas Pinter, Luis Puig, Knut Schaekel, Adam Reich, Shirin Zaheri, Antonio Costanzo, Tsen Fang Tsai, Saxon D. Smith, Charles Lynde, Alan Brnabic, Catherine Reed, Julie Hill, Christopher Schuster, Elisabeth Riedl, Carle Paul

Summary: This study compares the effectiveness of anti-interleukin (IL)-17A biologics with other approved biologics in patients with moderate-to-severe psoriasis. The results demonstrate that anti-IL-17A biologics have better efficacy in patients compared to other biologics, consistent with previous clinical trial findings.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Add to Collection

Article Rheumatology

EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology

Delphine Sophie Courvoisier, Kim Lauper, Joanna Kedra, Maarten de Wit, Bruno Fautrel, Thomas Frisell, Kimme L. Hyrich, Florenzo Iannone, Pedro M. Machado, Lykke Midtboll Ornbjerg, Ziga Rotar, Maria Jose Santos, Tanja A. Stamm, Simon R. Stones, Anja Strangfeld, Sytske Anne Bergstra, Robert B. M. Landewe, Axel Finckh

Summary: The European Alliance of Associations for Rheumatology (EULAR) has developed a set of points to consider (PtC) for analyzing and reporting comparative effectiveness research using observational data in rheumatology, aiming to reduce biases and improve the trustworthiness of the research results.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Review Medicine, General & Internal

Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies

Daniela Pugliese, Sara Onali, Giuseppe Privitera, Alessandro Armuzzi, Claudio Papi

Summary: The drug pipeline for the treatment of inflammatory bowel disease has expanded over the years, and comparative effectiveness research (CER) helps identify the differences in efficacy and safety outcomes among different therapeutic regimens. CER includes network meta-analyses, head-to-head trials, and real-world studies, each providing answers to different questions.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Dermatology

Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort

Carlos Pelayo Hernandez-Fernandez, Gregorio Carretero, Raquel Rivera, Carlos Ferrandiz, Esteban Dauden, Pablo De la Cueva, Isabel Belinchon, Francisco Javier Gomez-Garcia, Enrique Herrera-Acosta, Diana P. Ruiz-Genao, Marta Ferran, Merce Alsina, Ofelia Baniandres-Rodriguez, Jose Luis Sanchez-Carazo, Rafael Botella-Estrada, Antonio Sahuquillo-Torralba, Lourdes Rodriguez, Jaime Vilar-Alejo, Carmen Garcia-Donoso, Jose M. Carrascosa, Mar Llamas-Velasco, Enrique Herrera-Ceballos, Jose Luis Lopez-Estebaranz, Conrad Pujol-Marco, Miguel Angel Descalzo, Ignacio Garcia-Doval

Summary: This study found that women with psoriasis are more likely to be prescribed biologics than men, but there were no significant differences between sexes in terms of treatment effectiveness and risk of adverse events. Limitations of the study include residual confounding and the use of drug survival as a proxy for effectiveness.

ACTA DERMATO-VENEREOLOGICA (2021)

Add to Collection

Article Rheumatology

Tolerability and comparative effectiveness of TNF, IL-17 and IL-23(p19) inhibitors in psoriatic arthritis: a target trial emulation study

Zara R. Stisen, Sabrina M. Nielsen, Marie Skougaard, Mette Mogensen, Tanja Schjodt Jorgensen, Lene Dreyer, Maarten de Wit, Robin Christensen, Lars Erik Kristensen

Summary: This study compared the tolerability and effectiveness of IL-17i, IL-23(p19)i, and TNFi in treating patients with PsA. The results showed that there were no significant differences in drug survival rates and treatment outcomes among the three drugs after 12 months.

RHEUMATOLOGY (2023)

Add to Collection

Article Rheumatology

Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis

Maria Laura Acosta Felquer, Luciano LoGiudice, Maria Laura Galimberti, Javier Rosa, Luis Mazzuoccolo, Enrique R. Soriano

Summary: The study found that using biologics in patients with psoriasis can reduce the risk of developing psoriatic arthritis (PsA).

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Review Pharmacology & Pharmacy

Comparative Effectiveness of Pharmacological Interventions for Covid-19: A Systematic Review and Network Meta-Analysis

Franco De Crescenzo, Laura Amato, Fabio Cruciani, Luke P. Moynihan, Gian Loreto D'Alo, Simona Vecchi, Rosella Saulle, Zuzana Mitrova, Valeria Di Franco, Antonio Addis, Marina Davoli

Summary: Various pharmacological interventions for Covid-19 are being investigated, with corticosteroids reducing all-cause mortality, remdesivir appearing to be a safer option than standard care or placebo, and concerns about the safety of plasma. The evidence is evolving rapidly and should guide clinical practice until more data becomes available.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Oncology

Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data

Daniel D. Joyce, Kevin M. Wymer, Vidit Sharma, James P. Moriarty, Bijan J. Borah, Daniel M. Geynisman, Elizabeth R. Plimack, Brian A. Costello, Lance C. Pagliaro, Stephen A. Boorjian

Summary: Neoadjuvant ddMVACx6 was more cost-effective than GCx4 for muscle-invasive bladder cancer.

CANCER (2022)

Add to Collection

Review Public, Environmental & Occupational Health

A Review of Major Danish Biobanks: Advantages and Possibilities of Health Research in Denmark

Kristina Laugesen, Jonas Mengel-From, Kaare Christensen, Jorn Olsen, David M. Hougaard, Lasse Boding, Anja Olsen, Christian Erikstrup, Merete Lund Hetland, Estrid Hogdall, Alisa Kjaergaard, Erik Sorensen, Anja Brugmann, Eva Rabing Brix Petersen, Ivan Brandslund, Borge Nordestgaard, Gorm B. Jensen, Nils Skajaa, Frederikke Schonfeldt Troelsen, Cecilia Hvitfeldt Fuglsang, Lise Skovgaard Svingel, Henrik T. Sorensen

Summary: Denmark has a rich source of biobanks and a comprehensive healthcare system, which allows for the integration of biological specimens with clinical and demographic data for biobank research. This can contribute to a better understanding of disease etiology and personalized medicine.

CLINICAL EPIDEMIOLOGY (2023)

Add to Collection

Article Dermatology

Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database

Laura Pina Vegas, Laetitia Penso, Pascal Claudepierre, Emilie Sbidian

Summary: This cohort study suggests that IL-17 inhibitors show higher treatment persistence compared to TNF inhibitors for Psoriasis (PsO) and psoriatic arthritis (PsA). IL-17 inhibitors also demonstrate higher persistence in PsA compared to IL-12/23 inhibitors, with no difference noted for PsO. However, the overall persistence rates for all biologics remain relatively low at 3 years.

JAMA DERMATOLOGY (2022)

Add to Collection

Letter Dermatology

Prescriptions for scabies are rapidly increasing in Spain: An ecological study with national prescription data, 2008-2021

Eliseo Martinez-Garcia, Merce Grau-Perez, Agustin Buendia-Eisman, Ignacio Garcia-Doval

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Add to Collection

Article Dermatology

Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce

Angela L. Bosma, Annelie H. Musters, Manja Bloem, Louise A. A. Gerbens, Maritza A. Middelkamp-Hup, Eva Haufe, Jochen Schmitt, Sebastien Barbarot, Julien Seneschal, Delphine Staumont-Salle, Emma K. Johansson, Maria Bradley, Laura B. von Kobyletzki, Ida Vittrup, Iben Frier Ruge, Jacob P. Thyssen, Christian Vestergaard, Marina de Vega, Ignacio Garcia-Doval, Andrea Chiricozzi, Luca Stingeni, Piergiacomo Calzavara-Pinton, Michael R. Ardern-Jones, Nick J. Reynolds, Carsten Flohr, Phyllis Spuls

Summary: The TREAT Registry Taskforce is a collaborative network collecting real-world data on atopic eczema patients. This study provides an overview of the eight established TREAT registries and examines the overlap and pooling ability of their datasets. The results show that pooled analyses can be performed on multiple important domain items, enabling future comparative analyses.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Add to Collection

Article Dermatology

Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry

Cristina Muniesa, Fernando Gallardo, Ignacio Garcia-Doval, M. Teresa Estrach, Andrea Combalia, Mercedes Morillo-Andujar, Fatima De la Cruz-Vicente, Salma Machan, Cristina Moya-Martinez, Roger Rovira, Blanca Sanchez-Gonzalez, Elvira Acebo, Elena Amutio, Yeray Penate, Maria Del Carmen Losada-Castillo, M. Pilar Garcia-Muret, Helena Iznardo, Concepcion Roman-Curto, Javier Canueto, Ricardo Fernandez-de-Misa, Angeles Florez, Rosa Maria Izu, Ignacio Torres-Navarro, Ana Zayas, Gema Perez-Paredes, Mar Blanes, J. Ignacio Yanguas, Amparo Perez-Ferriols, Marta Callejas-Charavia, Pablo Luis Ortiz-Romero, Amalia Perez-Gil, Lucia Prieto-Torres, Eva Gonzalez-Barca, Octavio Servitje

Summary: This study evaluated the response and tolerance of brentuximab vedotin (BV) in patients with CD30-expressing cutaneous T-cell lymphoma (CTCL). The results showed that BV had efficacy and safety in patients with advanced-stage mycosis fungoides (MF) and CD30+ lymphoproliferative disorders (CD30 LPD). Additionally, patients with folliculotropic MF (FMF) and Sezary syndrome (SS) also showed a favorable response.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Add to Collection

Letter Dermatology

Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain

Fatima Tous-Romero, Ana Maria Gimenez-Arnau, Tatiana Sanz-Sanchez, Ricardo Gonzalez Perez, Jose Manuel Carrascosa-Carrillo, Violeta Zaragoza-Ninet, Susana Cordoba-Guijarro, Maria Elena Gatica-Ortega, Javier Miquel-Miquel, Leopoldo Borrego-Hernando, Inmaculada Ruiz-Gonzalez, Esther Serra-Baldrich, Juan Francisco Silvester-Salvador, Pedro Mercader-Garcia, Javier Sanchez-Perez, Mercedes Rodriguez-Serna, Antonia Pastor-Nieto, Marcos Hervella-Garcia, Ignacio Garcia-Doval, Francisco Javier Ortiz-de Frutos

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Add to Collection

Editorial Material Dermatology

Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice

Esther E. Freeman, Ignacio Garcia-Doval, Luigi Naldi, Roderick J. Hay

BRITISH JOURNAL OF DERMATOLOGY (2023)

Add to Collection

Article Dermatology

The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort study

Angela L. Bosma, Louise A. A. Gerbens, Hajar El Khattabi, Floris C. Loeff, Michael Duckworth, Richard T. Woolf, Theo Rispens, Catherine H. Smith, Phyllis I. Spuls

Summary: This study investigated the clinical relevance of dupilumab serum concentration in atopic dermatitis patients. The results showed that the concentration of dupilumab is not associated with treatment effectiveness, but disease activity does seem to influence its levels.

JOURNAL OF DERMATOLOGICAL TREATMENT (2023)

Add to Collection

Letter Dermatology

Effectiveness and patient satisfaction of a Dutch patient decision aid for psoriasis - a pilot study

A. M. van Huizen, N. J. Rietbergen, G. E. van der Kraaij, D. T. Ubbink, Ph. I. Spuls

JOURNAL OF DERMATOLOGICAL TREATMENT (2023)

Add to Collection

Editorial Material Medicine, General & Internal

The Disruptive Force of Real-World Evidence

Marcus Schmitt-Egenolf

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Review Surgery

Measurement instruments for the core outcome set of congenital melanocytic naevi and an assessment of the measurement properties according to COSMIN: a systematic review

A. C. Fledderus, T. Boom, C. M. Legemate, C. M. A. M. van der Horst, P. I. Spuls

Summary: This study aims to update a systematic review and evaluate the measurement properties of instruments for the core outcomes of congenital melanocytic naevi (CMN). The first step involves literature search to identify core outcomes and instruments used in previous research. The second step includes a systematic search for studies on the measurement properties of these instruments. The study concludes that further research is needed to determine the appropriate measurement instruments for the core outcomes of CMN.

JPRAS OPEN (2023)

Add to Collection

Article Dermatology

Prolonged Sick Leave Before and After Diagnosis of Generalized Pustular Psoriasis: A Swedish Population-based Register Study

Sofia Lofvendahl, Jenny M. Norlin, Oskar Ericson, Malin Hanno, Marcus Schmitt-Egenolf

Summary: This study analyzed the sick leave situation in patients with generalized pustular psoriasis and found that the number of sick leave days was significantly higher in these patients compared to the control groups. The study also indicated that the sick leave days were already higher prior to diagnosis, suggesting delayed diagnosis and/or a comorbidity burden.

ACTA DERMATO-VENEREOLOGICA (2023)

Add to Collection

Letter Dermatology

Harmonization of outcomes in epidermolysis bullosa: report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meeting

Eva W. H. Korte, Phyllis Spuls, Peter C. van den Akker, Dimitra Kiritsi, Martin Laimer, Anna M. G. Pasmooij, Rainer Riedl, Elizabeth Vroom, Verena Wally, Tobias Welponer, Maria C. Bolling

Summary: The COSEB kick-off meeting in April 2023 emphasized the need for reasonable harmonization of outcome measurement in different types of epidermolysis bullosa (EB) through the development of core outcome sets. The standardized and uniform outcome assessment has the potential to reduce selective reporting, improve comparability and pooling of treatment outcomes, and enhance future research efficacy in EB.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Add to Collection

Letter Dermatology

Expanding the molecular and clinical spectrum of autosomal recessive congenital ichthyosis caused by pathogenic variants in NIPAL4 and PNPLA1 and evaluation of novel therapeutic interventions

S. V. J. Rossel, J. M. K. Clabbers, P. M. Steijlen, P. C. van den Akker, P. I. Spuls, M. A. Middelkamp Hup, M. C. van Maarle, M. Vreeburg, M. C. Bolling, M. van Geel, A. Gostynski

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Add to Collection

Article Education & Educational Research

The effects of procedural and conceptual knowledge on visual learning

Nadja Beeler, Esther Ziegler, Andreas Volz, Alexander A. Navarini, Manu Kapur

Summary: Combining procedural and conceptual knowledge improves learning outcomes in medical image evaluation. Although both teaching methods significantly and persistently impacted students' diagnostic accuracy, only students with combined procedural and conceptual knowledge significantly improved their diagnostic performance in classifying lesions they had seen before.

ADVANCES IN HEALTH SCIENCES EDUCATION (2023)

Add to Collection

Article Medicine, General & Internal

The Influence of Socioeconomic Factors on Access to Biologics in Psoriasis

Jenny M. Norlin, Sofia Loefvendahl, Marcus Schmitt-Egenolf, Stamatis Gregoriou, Emmanuel Andres

Summary: This study investigated the influence of socioeconomic factors on access to biologics for psoriasis. The findings showed that, after adjusting for disease severity and lifestyle factors, the higher-income group had better access to biologics compared to the middle-income group.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Engineering, Biomedical

Towards phase-sensitive optical coherence tomography in smart laser osteotomy: temperature feedback

Arsham Hamidi, Yakub A. Bayhaqi, Ferda Canbaz, Alexander A. Navarini, Philippe C. Cattin, Azhar Zam

Summary: This study investigates the potential of optical coherence tomography (OCT) to provide temperature feedback during bone surgery using Er:YAG laser. By relating the temperature rise with the photo-thermal expansion of the tissue, OCT can predict the temperature increase during laser ablation. The findings suggest that this method could be used for temperature feedback in minimally invasive laser osteotomy.

LASERS IN MEDICAL SCIENCE (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.